Experimental studies are paving the way for major developments in lupus research, reports HealthDay. Scientists have analyzed the effects of two new treatments that target the immune system response that causes the debilitating disease.
Researchers at the American College of Rheumatology’s annual meeting reportedly presented their findings regarding the use of vitamin D to treat lupus, as well as a vaccine that fights off interferon alpha, a protein present in the immune system.
“This is an incredibly exciting time in lupus research. The academic and pharmaceutical communities are involved in studies that will hopefully lead to more effective and safer treatments,” Dr. Cynthia Aranow of New York’s Feinstein Institute for Medical Research told the news source.
Lupus is a very difficult condition to treat. It is an autoimmune disease, which means that the immune system mistakenly attacks its own healthy cells. Because this system helps protects the body from infection and other health issues, treatments cannot shut down the immune system entirely, rather scientists must find the proteins that cause lupus to develop.
In the experimental studies, patients who received a high dose of vitamin D weekly for four weeks, then monthly for the following six months, saw their immune cells increase and calcium levels normalize. Interferon alpha (IFNa) was the subject of the second study.
“We were able to demonstrate that the IFNa signature (in excess in lupus patients) can be turned down by vaccinating patients against their own IFNa. [The drug is modified], devoid of IFNa biological activity, but modified in such a way that it becomes recognized by the immune system of the patient,” Dr. Frederic Houssiau, head of rheumatology at the Catholic University of Louvain in Brussels, explained to the news provider.
Further research must be done to confirm the positive results of these studies, but they are a step in the right direction and those suffering from lupus may want to stay tuned.

